Edwards Lifesciences Corp

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP EW

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

428,621

Value ($000)

36,540

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	36,540	0.0%	428,621	12/31/2025
2025 Q3	11/13/2025	21,929	0.0%	281,970	9/30/2025
2025 Q2	8/13/2025	12,034	0.0%	153,874	6/30/2025
2025 Q1	5/14/2025	19,284	0.0%	266,056	3/31/2025
2024 Q4	2/12/2025	3,404	0.0%	45,988	12/31/2024
2024 Q3	11/14/2024	5,925	0.0%	89,784	9/30/2024
2024 Q2	8/14/2024	20,785	0.0%	225,020	6/30/2024
2024 Q1	5/15/2024	81,895	0.1%	857,006	3/31/2024
2023 Q4	2/14/2024	80,961	0.1%	1,061,784	12/31/2023
2023 Q3	11/14/2023	100,567	0.1%	1,451,599	9/30/2023
2023 Q2	8/14/2023	198,480	0.2%	2,104,099	6/30/2023
2023 Q1	5/15/2023	174,426	0.2%	2,108,373	3/31/2023
2022 Q4	2/14/2023	203,632	0.3%	2,729,279	12/31/2022
2022 Q3	11/14/2022	200,868	0.3%	2,430,928	9/30/2022
2022 Q2	8/15/2022	265,923	0.4%	2,796,541	6/30/2022
2022 Q1	5/13/2022	389,904	0.5%	3,312,133	3/31/2022
2021 Q4	2/14/2022	422,462	0.5%	3,260,993	12/31/2021
2021 Q3	11/12/2021	288,920	0.4%	2,552,072	9/30/2021
2021 Q2	8/13/2021	153,028	0.2%	1,477,534	6/30/2021
2021 Q1	5/14/2021	80,735	0.1%	965,269	3/31/2021
2020 Q4	2/12/2021	2,137	0.0%	23,419	12/31/2020
2020 Q3	11/12/2020	21,239	0.0%	266,080	9/30/2020
2020 Q2	8/12/2020	127,084	0.2%	1,838,872	6/30/2020
2020 Q1	5/15/2020	155,395	0.4%	823,850	3/31/2020
2019 Q4	2/13/2020	127,315	0.3%	545,736	12/31/2019